Mathias Busekist
Nearly 18,000 containers of ice cream and frozen yogurt are being recalled due to batches possibly containing pieces of plastic.
Wells Enterprises, the manufacturer behind popular frozen treats like Blue Bunny and Halo Top, has issued a voluntary recall of nearly 18,000 containers of ice cream and frozen yogurt over concerns that the products may contain small pieces of plastic.
The Iowa-based company initiated the recall on April 25, according to a recent report from the U.S. Food and Drug Administration (FDA). The affected products span 22 different flavors packaged in three-gallon tubs, which were distributed to more than 100 locations across the United States, including in Iowa, Michigan, Illinois, and Texas.
The recalled batches bear “Use by” dates ranging from March 2026 to October 2026. While no injuries or adverse reactions have been reported so far, the FDA has classified the recall as a Class II event — meaning the products could cause temporary or medically reversible health issues if consumed.
The presence of foreign materials such as plastic in food products poses risks including choking, cuts to the mouth or throat, and digestive issues. Though the risk is considered moderate, the FDA and Wells Enterprises are urging distributors and customers to check inventory and dispose of or return affected products.
The recall affects primarily bulk items sold for food service use, such as in restaurants, cafeterias, and ice cream parlors, rather than pints or other retail-sized containers typically found in grocery stores. However, consumers are advised to remain cautious, especially if they suspect they’ve been served one of the affected products.
Wells Enterprises has not publicly commented on the cause of the contamination but has directed consumers and distributors to consult the full list of affected products on the FDA’s website for batch numbers and additional identifying information.
The company has emphasized that product safety is a top priority and that it is cooperating fully with the FDA to ensure the issue is resolved swiftly and thoroughly.